TIDMMEN
RNS Number : 8119A
Molecular Energies PLC
24 January 2024
THIS ANNOUNCEMENT (THE "ANNOUNCEMENT"), AND THE INFORMATION
CONTAINED IN IT, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION,
DISTRIBUTION OR FORWARDING, IN WHOLE OR IN PART, DIRECTLY OR
INDIRECTLY, IN, INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA,
JAPAN, NEW ZEALAND, THE REPUBLIC OF SOUTH AFRICA OR ANY OTHER STATE
OR JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE
RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. PLEASE SEE THE
IMPORTANT NOTICES AT THE END OF THIS ANNOUNCEMENT.
THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND DOES NOT
CONSTITUTE OR CONTAIN ANY INVITATION, SOLICITATION, RECOMMENDATION,
OFFER OR ADVICE TO ANY PERSON TO SUBSCRIBE FOR, OTHERWISE ACQUIRE
OR DISPOSE OF ANY SECURITIES IN MOLECULAR ENERGIES PLC OR ANY OTHER
ENTITY IN ANY JURISDICTION. NEITHER THIS ANNOUNCEMENT NOR THE FACT
OF ITS DISTRIBUTION SHALL FORM THE BASIS OF, OR BE RELIED ON IN
CONNECTION WITH, ANY INVESTMENT DECISION IN RESPECT OF MOLECULAR
ENERGIES PLC.
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED
UNDER THE MARKET ABUSE REGULATION (EU NO. 596/2014) AS IT FORMS
PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION
(WITHDRAWAL) ACT 2018 (AS AMENDED) ("MAR"). UPON THE PUBLICATION OF
THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE
INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.
MOLECULAR ENERGIES PLC
("Molecular" or the "Company")
Result of Fundraising
Molecular Energies (AIM: MEN), the international energy company,
is pleased to announce that, further to the announcement made at
7.00 a.m. on 24 January 2024 (the "ABB Announcement") it has
successfully raised GBP0.65 million (before expenses) pursuant to
the Placing and Subscription of 1,852,824 New Ordinary Shares at
the Issue Price.
Capitalised terms in the announcement shall have the same
meaning ascribed to them as in the ABB Announcement unless the
context requires otherwise.
Cavendish Capital Markets Limited ("Cavendish") acted as
bookrunner to the Placing.
ADMISSION
The Company is issuing 1,852,824 New Ordinary Shares pursuant to
the Placing and Subscription, representing 17.9 per cent. of the
Company's issued share capital at the date of this Announcement.
The Company has the authority to issue and allot the New Ordinary
Shares pursuant to certain existing shareholder authorities
granting such powers to the directors at the Company's Annual
General Meeting held on 21 September 2023.
The New Ordinary Shares will, when issued, be credited as fully
paid up and will be issued subject to the Articles and rank pari
passu in all respects with the Company's existing Ordinary Shares,
including the right to receive all dividends and other
distributions declared, made or paid on or in respect of the
Ordinary Shares after the date of issue of the New Ordinary Shares,
and will on issue be free of all claims, liens, charges,
encumbrances and equities.
Application has been made to the London Stock Exchange for the
admission of the New Ordinary Shares to trading on AIM
("Admission"). It is expected that Admission will occur on or
around 8.00 a.m. on 26 January 2024.
Following Admission, the total number of Ordinary Shares in the
capital of the Company in issue will be 12,218,197 with each
Ordinary Share carrying the right to one vote. There are no
Ordinary Shares held in treasury and therefore the total number of
voting rights in the Company is 12,218,197. The above figure may be
used by shareholders in the Company as the denominator for the
calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in, the
share capital of the Company under the Financial Conduct
Authority's Disclosure Guidance and Transparency Rules.
For more information, please visit www.molecularenergiesplc.com
or contact:
Molecular Energies PLC +44 (0)20 7016 7950
Peter Levine, Chairman info@molecularenergiesplc.com
Rob Shepherd, Group FD
Cavendish Capital Markets Limited (Nominated
Adviser & Broker)
Simon Hicks, George Dollemore +44 (0)20 7220 0500
Tavistock (Financial PR & IR)
Simon Hudson, Nick Elwes, Charles Baister +44 (0)20 7920 3150
This Announcement is released by Molecular Energies plc and
contains inside information for the purposes of Article 7 of MAR,
and is disclosed in accordance with the Company's obligations under
Article 17 of MAR.
Market soundings (as defined in MAR) were taken in respect of
the Placing with the result that certain persons became aware of
inside information (as defined in MAR), as permitted by MAR. This
inside information is set out in this Announcement. Therefore,
those persons that received inside information in a market sounding
are no longer in possession of such inside information relating to
the Company and its securities.
For the purposes of MAR, Article 2 of Commission Implementing
Regulation (EU) 2016/1055 and the UK version of such implementing
regulation (as amended), the person responsible for arranging for
the release of this Announcement on behalf of the Company is Peter
Levine, Chairman.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
IOEEASFLAFNLEFA
(END) Dow Jones Newswires
January 24, 2024 10:22 ET (15:22 GMT)
Molecular Energies (LSE:MEN)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Molecular Energies (LSE:MEN)
Historical Stock Chart
Von Dez 2023 bis Dez 2024
